Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $36.22M in the quarter ending March 31, 2026, with 77.54% growth. This brings the company's revenue in the last twelve months to $122.29M, up 201.29% year-over-year. In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth.

• Revenue (ttm): $122.29M
• Revenue Growth: +201.29%
• P/S Ratio: 5.38
• Revenue / Employee: $2,004,738
• Employees: 61
• Market Cap: 657.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	106.47M	82.86M	350.91%
Dec 31, 2024	23.61M	-3.85M	-14.02%
Dec 31, 2023	27.46M	17.00M	162.58%
Dec 31, 2022	10.46M	-18.19M	-63.50%
Dec 31, 2021	28.65M	15.36M	115.61%
Dec 31, 2020	13.29M	449.00K	3.50%
Dec 31, 2019	12.84M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error